Molecular Diagnostics tests in Dubai & UAE

This test uses PCR-STR analysis of 24 autosomal loci to determine the biological relationship between an alleged mother and a child.

This test identifies specific genetic mutations responsible for monogenic diabetes (MODY).

This test detects pathogenic variants in the MAX gene associated with hereditary pheochromocytoma-type 9 and paraganglioma syndrome.

This test evaluates the MC2R gene for variants associated with familial glucocorticoid deficiency type 1.

This test identifies the animal species present in a meat or processed food sample using DNA analysis and proteomics.

This diagnostic test evaluates the MED25 gene for mutations associated with Charcot-Marie-Tooth disease type 2B2 (CMT2B2), a hereditary neuropathy.

This test evaluates genome-wide DNA methylation patterns using MeDIP-Seq technology.

This test evaluates genome-wide DNA methylation patterns to identify epigenetic signatures associated with disease.

This test evaluates genome-wide DNA methylation patterns using immunoprecipitation and next-generation sequencing.

This test evaluates genome-wide DNA methylation patterns using MeDIP-Seq methodology.

This test detects mutations in the RET gene, which are associated with Medullary Thyroid Carcinoma (MTC). It helps identify hereditary forms of MTC and guides treatment decisions.

This test detects mutations in the MEN1 gene associated with Multiple Endocrine Neoplasia Type 1.

This test detects MERS-CoV RNA using multiplex RT-PCR targeting upE, ORF1a, and ORF1b genes, with reflex WGS for differentiation and variant identification.

This genetic test evaluates the MET gene for germline mutations associated with an increased risk of hereditary papillary renal cell carcinoma type 1.

This diagnostic test evaluates the presence and degree of MET gene amplification in archival tumor tissue using Fluorescence In Situ Hybridization (FISH).